The MCH receptor family: Feeding brain disorders?

Current Opinion in Pharmacology

Volumn 3, Issue 1, 2003, Pages 85-89

  Forray, Carlos ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

[N [6 (DIMETHYLAMINO) METHYL] 5,6,7,8 TETRAHYDRO 2 NAPHTHAPHENYL] 4V FLUORO[1,1V BISPHENYL] 4 CARBOXAMIDE; AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; ANXIOLYTIC AGENT; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; FENFLURAMINE; FLUOXETINE; G PROTEIN COUPLED RECEPTOR; GHRELIN; GLUCAGON LIKE PEPTIDE; HORMONE RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; LEPTIN; LEPTIN RECEPTOR; MELANIN CONCENTRATING HORMONE; METHYL 3 [[[3 [4 [3 (ACETYLAMINO)PHENYL] 1 PIPERIDINYL]PROPYL]AMINO]CARBONYL] 4 (3,4 DIFLUOROPHENYL) 6 (METHOXYMETHYL) 2 OXO 1,2,3,4 TETRAHYDRO 5 PYRIMINDINECARBOXYLIC ACID; MUSCARINIC M3 RECEPTOR; N (6 DIMETHYLAMINOMETHYL 5,6,7,8 TETRAHYDRO 2 NAPHTHYL) 4' FLUORO 1,1' BIPHENYL 4 CARBOXAMIDE; NEUROPEPTIDE Y; OREXIN; SEROTONIN UPTAKE INHIBITOR; SNAP 7941; SUBSTANCE P ANTAGONIST; UNCLASSIFIED DRUG;

ANOREXIA; ANXIETY; BRAIN DISEASE; DEPRESSION; DRUG MECHANISM; DRUG PENETRATION; DRUG STRUCTURE; ENERGY BALANCE; FEEDING BEHAVIOR; GENE DELETION; GENE TARGETING; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR BLOCKING; REVIEW;

ANIMALS; BRAIN DISEASES; EATING DISORDERS; FEEDING BEHAVIOR; HUMANS; RECEPTORS, PITUITARY HORMONE;

EID: 0037304178     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00013-9     Document Type: Review

References (40)

1. Dhillo WS, Bloom SR: Hypothalamic peptides as drug targets for obesity. Curr Opin Pharmacol 2001, 1:651-655.
2. Jequier E: Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci 2002, 967:379-388.
3. Elmquist JK: Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Int J Obes Relat Metab Disord 2001 25(Supl5):S78-S82.
4. Bittencourt JC, Elias CF: Melanin-concentrating hormone and neuropeptide EI projections from the lateral hypothalamic area and zona incerta to the medial septal nucleus and spinal cord: a study using multiple neuronal tracers. Brain Res 1998, 805:1-19.
5. Elmquist JK, Elias CF, Saper CB: From lessions to leptin: hypothalamic control of food intake and body weight. Neuron 1999, 22:221-232.
6. Schawartz MW, Morton GJ: Obesity: keeping hunger at bay. Nature 2002, 418:595-597.
7. Kennedy AR, Todd JF, Stanley SA, Abbott CR, Small CJ, Ghatel MA, Bloom SR: Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH)release, in vivo and in vitro, via the hypothalamus and the pituitary. Endocrinology 2001, 142:3265-3268.
8. Oldfield BJ, Giles ME, Watson A, Anderson C, Colvill LM, McKinley MJ: The neurochemical charaterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat. Neuroscience 2002, 110:515-526.
9. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przpek R, Kanarek R, Maratos-Flier E: A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996, 380:243-247.
10. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E: Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998, 396:670-674.
11. Ludwig DS, Mountjoy KG, Tatro JB, Gillette JA, Frederich RC, Flier JS, Maratos-Flier E: Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am J Physiol 1998, 274:E627-E633.
12. Saito Y, Nothacker HP, Wang Z, Lin SH, Leslie F, Civelli O: Molecular characterization of the melanin-concentrating-hormone receptor. Nature 1999, 400:265-269.
13. Chambers J, Ames RS, Bergsma D, Muier A, Fitzgerald LR, Hervieu G, Dytko GM, Foley JJ, Martin J, Liu WS et al.: Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor. SLC-1. Nature 1999, 400:261-265.
14. Hervieu GJ, Cluderay JE, Harrison D, Meakin J, Maycox P, Nasir S, Leslie RA: The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, sic-1, in the central nervous system of the rat. Eur J Neurosci 2000, 12:1194-1216.
15. Suply T, Della Zuana O, Audinot V, Rodriguez M, Beauverger P, Duhault J, Canet E, Galizzi JP, Nahon JL, Levens N, Bouth JA: SLC-1 receptor mediates effect of melanin-concentrating hormone on feedig behavior in rat: a structure-activity sutdy. J Pharmacol Exp Ther 2001, 299:137-146.
16. Audinot V, Beauverger P, Lahaye C, Suply T, Rodriguez M, Galizzi JP, Fauchere JL, Bouth JA: [1251]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor. Br J Pharmacol 2001, 133:371-378.
17. Audinot V, Beauverger P, Lahaye C, Suply T, Rodriguez M, Ouvry C, Lamamay V, Imbert J, Rique H, Nahon JL et al.: Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptie ligands at SLC-1, the human MCH recptor. J Biol Chem 2001, 76:13554-13562.
18. Sailer AW, Sano H, Zeng Z, McDonald TP, Pan J, Pong SS, Feighner SD, Tan CP, Fukami T, Iwaasa H et al.: Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc Natl Acad Sci USA 2001, 98:7564-7569.
19. Hill J, Duckworth M, Murdock P, Rennie G, Sabido-David C, Ames RS, Szekeres P, Wilson S, Bergsman DJ, Gloger IS et al.: Molecular cloning and functional characterization on MCH2, a novel human MCH receptor. J Biol Chem 2001, 276:20125-20129.
20. Rodriguez M, Beauverger P, Naime I, Rique H, Ouvry C, Souchaud S, Dromaint S, Nagel N, Suply T, Audinot V et al.: Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2. Mol Pharmacol 2001, 60:632-639.
21. Tan CP, Sano H, Iwaasa H, Pan J, Sailer AW, Hreniuk DL, Feighner SD, Palyha OC, Pong SS Figueroa DJ et al.: Melanin-concentrating hormone receptor subypes 1 and 2: sepcies-specific gene expression. Genomics 2002, 79:798-792.
22. Marsh DJ, Weingarth DT, Novi DE, Chen HY, Trumbauer ME, Chen AS, Guan XM, Jiang MM, Feng Y, Camacho RE et al: Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci USA 2002, 99:3240-3245.
23. Chen Y, Hu C, Hsu CK, Zhang Q, Bi C, Ashicar M, Hsiung HM, Fox N, Slieker LJ, Yang DD et al.: Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistrance to diet-induced obesity. Endocrinology 2002, 143:2469-2477.
24. Yamaha M, Miyakawa T, Duttaroy A, Yamanaka A, Moringuchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN et al.: Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 2001, 410:207-212.
25. Bednarek MA, Hreniuk DL, Tan C, Palyha OC, MacNeil DJ, Van der Ploeg LH, Howard AD, Feighner SD: Synthesis and biological evaluation in vitro of selective, high affinity hormone action at human melanin-concentrating hormone receptor-1. Biochemistry 2002, 41:6383-6389.
26. Takekawa S, Asami A, Ishihara Y, Terauchi J, Kato K, Shimomura Y, Mori M, Murakoshi H, Kato K, Suzuki N et al.: T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eur J Pharmacol 2002, 438:129-135.
27. Borowsky B, Durkin MM, Ogozalek K, Marzabadi MR, DeLeon J, Heurich R, Lichtblau H, Shaposhnik Z, Daniewska I, Blackburn TP et al.: Antidepressant, anxiolytic an anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 2002, 8:779-781.
28. Mondal MS, Nakazato M, Matsukura S: Characterization of orexins (hypocretins) and melanin-concentrating hormone in genetically obese mice. Regul Pept 2002, 104:21=25.
29. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKEE LJ, Bauer TL et al.: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996, 334:292-295.
30. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanoval, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV: Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resitance. Lancet 1996, 348:159-161.
31. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr: Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996, 2:589-593.
32. Seper CB, Chou TC, Elmquist JK: The need to feed: homeostatic and hedonic control of eating. Neuron 2002, 36:199-211.
33. Saito Y, Cheng M, Leslie FM, Civelli O: Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J Comp Neurol 2001, 435:26-40.
34. Lucki I: The forced swiming test as model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 1997, 8:523-532.
35. Cryan JF, Page ME, Luki I: Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol 2002, 436:197-205.
36. Gonzalez MI, Baker BI, Hole DR, Wilson CA: Behavioral effects of neuropeptide E-I (NEI) in the female rat: Interactions with alpha-MSH, MCH and dopamine. Peptides 1998, 19:1007-1016.
37. Collin M, Backberg M, Onnestam K, Meister B: 5-HT1A receptor immunoreactivity in hypothalamic neuron involved in body weight control. Neuroreport 2002, 13:945-951.
38. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E et al.: Distinct mechanism for antiepressant activity by blockade of central substance P receptors. Science 1998, 281:1640-1645.
39. Sanchez MS, Barontini M, Armando I, Cells ME: Correlation of increased grooming behavior and motor activity with alterations in nigrostriatal and mesolimbic catecholamines after alpha-melanotropin and neuropeptide glutamine-isoleucine injection in the rat ventral tegmental area. Cell Mol Neurobiol 2001, 21:523-533.
40. Sanchez M, Baker BI, Cells M: Melanin-concentrating hormone (MCH) antagonizes the effects of alpha-MSH and neuropeptide E-I on grooming and locomotor activities in the rat. Peptides 1997, 18:393-396.